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We previously showed that treatment with resveratrol (3,5,4’-trihydroxy-trans-
stilbene), an activator of the NAD+-dependent deacetylase SIRT1 at 4 g/kg food for 
32 weeks significantly decreased the muscular reactive oxygen species (ROS) 
levels and ameliorated the pathology of mdx mice, an animal model of Duchenne 
muscular dystrophy (DMD). Here we treated mdx mice with various doses of 
resveratrol (0.04, 0.4, and 4 g/kg food) for 56 weeks and examined the effects on 
serum creatine kinase levels and physical activities. Because resveratrol promotes 
autophagy, we also investigated whether autophagy including mitochondrial 
autophagy (mitophagy) is involved in resveratrol’s effects. Autophagy/mitophagy-
related genes and autophagic flux were downregulated in the muscle of mdx mice, 
and these phenomena were reversed by resveratrol with significant ROS reduction. 
Resveratrol at 4 g/kg food reduced the number of immature myofibers containing 
central nuclei and fine fibers < 400 m2, and increased that of thicker myofibers in 
the quadriceps, suggesting that resveratrol decreased myofiber wasting and 
promoted muscular maturation. Accordingly, resveratrol at 0.4 g/kg food reduced 
the creatine kinase levels to one-third of those in untreated mdx mice and 
significantly increased the animals’ physical activities. In C2C12 myoblast cells, 
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resveratrol promoted mitophagy and eliminated mitochondria containing high 
superoxide levels. The clearance of damaged mitochondria and ROS reduction by 
resveratrol were completely suppressed by an autophagy inhibitor (chloroquine) 
and by knocking down Atg5 or Pink1, essential genes for autophagy and mitophagy, 
respectively. Thus, resveratrol is a potential therapeutic agent for DMD, and the 




1. Introduction  
Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy, in 
which mutations of the dystrophin gene lead to progressive muscle wasting and 
degeneration [1]. Few treatments exist for DMD except for glucocorticoids, which 
increase muscle strength and functional measures in the short term, although their 
ability to extend walking ability for more than two years is unclear [2]. Furthermore, the 
long-term glucocorticoid use may cause prediabetes and osteoporosis, and 
glucocorticoids are not thought to improve myogenesis or fibrosis [2, 3]. 
SIRT1, an NAD+-dependent protein deacetylase, regulates transcription machineries 
and plays pivotal roles in controlling metabolism, inflammation, differentiation, and 
DNA repair [4]. SIRT1 promotes cell survival by reducing oxidative stress and by 
increasing mitochondrial biogenesis by deacetylating and activating Forkhead Box O 
transcription factors (FOXOs) and peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC-1α) [4]. Resveratrol (3,5,4’-trihydroxy-trans-stilbene), a 
natural polyphenol found in grapes and red wine, is an activator of SIRT1 [5]. We found 
that resveratrol at a dose of 4 g/kg food ameliorates the skeletal muscle and cardiac 
pathologies of dystrophin-deficient mdx mice [6, 7]. Beneficial effects of resveratrol in 
mdx mice have also been reported by other groups [8, 9, 10], and SIRT1 
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overexpression in mdx mice was shown to reduce muscle damage and improve 
function [11].  
In the heart, resveratrol induces reactive oxygen species (ROS)-detoxifying enzyme 
superoxide dismutase 2 (SOD2) by activating nuclear SIRT1, thereby decreasing 
oxidative damage [12]. Resveratrol also inhibits myocardial hypertrophy and fibrosis 
by promoting SIRT1’s deacetylation of coactivator p300, which then undergoes 
ubiquitin-dependent degradation [7].  
Surprisingly, SOD2 levels in the skeletal muscle of mdx mice were not significantly 
elevated by resveratrol, possibly because SIRT1 was not concentrated in the nuclei of 
myofibers [6]. Although resveratrol suppressed the up-regulation of NADPH oxidase 
subunits, resveratrol and SIRT1 may use another mechanism to reduce ROS levels in 
the muscle of mdx mice.  
Autophagy is a process that digests unnecessary or dysfunctional components in cells. 
SIRT1 promotes autophagy by deacetylating and activating autophagic components 
such as Atg5, Atg7, and LC3 [13, 14], and resveratrol induces autophagy by activating 
cytoplasmic SIRT1 [15, 16]. Damaged or dysfunctional mitochondria, the major source 
of ROS in most cells [17], are eliminated by an autophagic process called mitophagy 
[18, 19, 20]. The loss of membrane potential in damaged mitochondria causes PTEN-
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induced putative kinase 1 (Pink1) to accumulate on their outer membrane, where Pink1 
recruits, phosphorylates, and activates parkin, a ubiquitin ligase. The activated parkin 
recruits p62, an autophagy adaptor protein, to the damaged mitochondria, leading to 
encapsulation of the damaged mitochondria by LC3 in autophagosomes; the 
mitochondria are then degraded in lysosomes [18, 19, 20]. Autophagy insufficiency 
induced by the knockout of autophagy/mitophagy-related genes such as Atg3, Atg5, 
Atg7, LC3B, and Pink1 causes a significant increase in cellular ROS [19], suggesting 
that ROS are liberated from damaged mitochondria that escape mitophagy. In addition, 
the muscle-specific knockout of Atg5 or Atg7 results in muscle atrophy, dysfunction, 
and myopathy [21, 22]. Notably, mitochondria in the muscle of Atg7-null mice are 
morphologically and functionally abnormal [23]. Loss-of-function mutants of Pink1 or 
parkin, mitophagy-related genes, show mitochondrial dysfunction and flight muscle 
degeneration in Drosophila [24, 25]. Thus, mitophagy may have a role in the pathology 
of muscular dystrophies. 
Here, we examined autophagy/mitophagy in mdx mice and in C2C12 myoblast cells. 
Because resveratrol can act as a mitochondrial depolarizing agent [26], and because 
a low dose of resveratrol (2.5 mg/kg/day) improves insulin resistance in mice [27], we 
investigated the effects of lower doses of resveratrol, i.e., 0.04 and 0.4 g/kg food, as 
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well as 4 g/kg food, on mdx mice. Resveratrol increased the expression of 
autophagy/mitophagy-related genes and autophagic flux, and reduced ROS levels in 
the muscle of mdx mice. Furthermore, resveratrol improved the muscular pathology 
and physical strength of the mdx mice. We further showed that mitophagy was 




2. Materials and Methods 
2.1. Reagents and Antibodies.  
Resveratrol (185-01721) and Hoechst 33342 (346-07951) were from Wako Pure 
Chemicals (Osaka, Japan). Food grade resveratrol for mouse treatment was from 
ChromaDex (ASB-00018089-101, Irvine, CA). FITC-conjugated wheat germ agglutinin 
(WGA) lectin (W834), Dihydroethidium (DHE) (D1168), MitoSOX Red (M36008), 
MitoTracker Red (MTR, M7512), and Lipofectamine RNAiMAX Transfection Reagent 
(13778-150) were from Thermo Fisher Scientific (Rockford, IL). The RNeasy Fibrous 
Tissue Mini Kit (74704) was from Qiagen (Valencia, CA). The GoScript Reverse 
Transcription System (A6010), GoTaq qPCR Master Mix (A600A), and ViaFect 
Transfection Reagent (E4982) were from Promega (Madison, WI). Antimycin A 
(A8674) and chloroquine (CQ) (C6628) were from Sigma-Aldrich (St. Louis, MO). 
Plasmid EGFP-LC3 Expression Vector was from Addgene (#11546). siRNAs against 
mouse Atg5 (SASI_Mm01_00089196), mouse Pink1 (SASI_Mm02_00331134), and 
MISSION siRNA Universal Negative Control (SIC-001) were from Sigma Genosys 
Japan (Ishikari, Japan). Antibodies used were as follows: anti-LC3AB (#12741), anti-
phosho-Ser65-4EBP1 (#9451), anti-total 4EBP1 (#9452), and anti-ubiquitin (#3936) 
from Cell Signaling Technology (Beverly, MA), anti-p62 (GP62-C) from Progen 
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(Heidelberg, Germany), and anti-GAPDH (G8795) and anti-α-tubulin (T5168) from 
Sigma-Aldrich. 
2.2. Animals and Experimental Design.  
All in vivo experiments were conducted in strict accordance with the Guide for the Care 
and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) and 
approved by the Animal Care and Use Committee of Sapporo Medical University. Male 
C57BL/10ScSn-Dmdmdx/J mice (mdx mice) and age-matched C57BL10 mice were 
purchased from Oriental Yeast Co., Ltd. (Tokyo, Japan). C57BL10 mice served as WT. 
Muscle tissue samples were prepared at 22 weeks of age. In a series of experiments, 
the effects of resveratrol were analyzed in 24 mdx mice. mdx mice were orally given 0, 
0.04, 0.4, or 4 g resveratrol/kg food ad libitum from 9 weeks to 65 weeks of age (6 mice 
for each dose). At 65 weeks of age, the mice were sacrificed and their quadriceps were 
frozen in liquid nitrogen-cooled isopentane (Nacalai Tesque, Kyoto, Japan) and stored 
at -80°C until use.   
2.3. Gene Expression Assay.  
Total RNA was prepared from quadriceps muscles using the RNeasy Fibrous Tissue 
Mini Kit. Complementary DNA generated with the GoScript Reverse Transcription 
System was analyzed by the StepOne Real-Time PCR system (Applied Biosystems, 
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Foster City, CA) using the GoTaq qPCR Master Mix. Each sample was run in duplicate, 
and the mean value was used to calculate the mRNA level of the gene of interest. All 
data were normalized to 18s ribosomal RNA using the standard curve method. The 
primer sequences are listed in Supplemental Table 1. 
2.4. Western Blotting.  
Frozen quadriceps muscles were powdered by mortar and pestle, lysed in ice cold 
CelLytic M Tissue Lysis Reagent (C3228, Sigma-Aldrich) with a 1% protease inhibitor 
cocktail (25955-11, Nacalai Tesque, Kyoto, Japan) and 1% phosphatase inhibitor 
cocktail (07574-61, Nacalai Tesque), and centrifuged at 10,000 g for 10 min at 4°C. 
C2C12 samples were homogenized in ice cold CelLytic M Cell Lysis Reagent (C3228, 
Sigma-Aldrich) with the above-described protease inhibitor and phosphatase inhibitor 
cocktails. The protein concentration of the supernatant was measured using the 
Protein Quantification Kit-Rapid (PQ01, Dojindo, Kumamoto, Japan). Supernatant 
fractions of equal protein concentration were analyzed by Western blotting as 
described previously [6].  
2.5. Histological Analyses.  
Frozen muscles were embedded in optimal cutting temperature compound (Tissue-
Tek, Torrance, CA), and blocks were cross-sectioned mid-belly at 5 μm by cryostat at 
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-20°C. To monitor tissue ROS levels, sections of quadriceps muscles were incubated 
with 5 μM DHE (Thermo Fisher Scientific) for 30 min at 37°C and washed twice with 
PBS. The digital images were captured using an inverted confocal laser-scanning 
microscope (LSM510META; Zeiss, Germany) at 512 × 512 pixels, with a 63× oil 
immersion objective lens. The DHE fluorescence intensity was quantified by ImageJ 
software (National Institutes of Health, Bethesda, MD). The fluorescence intensity was 
measured from 6 randomly selected images of each muscle, and the average of 4 mice 
in each group was determined.   
To analyze cross-sectional areas, sections of quadriceps muscles were labeled with 
FITC-conjugated WGA. Nuclei were stained with Hoechst 33342. The digital images 
were captured by an LSM510META inverted confocal laser-scanning microscope, and 
the cross-sectional areas and central nuclei were quantified by ImageJ software. The 
cross-sectional areas of approximately 300 randomly selected myofibers per muscle 
were measured. The percentage of fibers with centrally located nuclei was analyzed in 
480-500 myofibers per muscle in each group. 
2.6. Cell Culture.  
C2C12 myoblast cells were cultured in Dulbecco’s modified Eagle’s medium (Wako 
Pure Chemical) supplemented with a 1% antibiotic-antimycotic mixed stock solution 
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(Nacalai Tesque) and 10% fetal bovine serum (MP Biomedicals, Solon, OH).  
2.7. Transfection of siRNA.  
Lipofectamine RNAiMAX Transfection Reagent was used to transfect siRNAs (30 nM) 
targeting Atg5 and Pink1, according to the manufacturer’s instructions. Cells were 
analyzed 48 h after transfection.  
2.8. Analysis of Mitophagy in C2C12 Cells.  
C2C12 cells were transfected with EGFP-LC3 using ViaFect Transfection Reagent 
(Promega) according to the manufacturer’s instructions, and then were stained with 
200 nM MTR 42 h after transfection. The cells were incubated with vehicle or 30 μM 
resveratrol for 6 h. In some samples, 50 μM CQ was added before the resveratrol 
treatment. After fixation, the colocalization of EGFP-LC3 with mitochondria was 
analyzed by confocal laser microscopy. After mitochondria take up MTR in a 
membrane potential-dependent manner, the MTR fluorescence is retained, even if the 
mitochondrial potential is lost during fixation. The number of EGFP-LC3 dots 
colocalized with MTR was counted in at least 30 randomly selected cells in each group, 
and 3 independent experiments were performed. 
2.9. Detection of Mitochondria and Mitochondrial ROS Levels.  
The mitochondrial superoxide levels in C2C12 cells were detected by MitoSOX Red 
13 
 
staining according to the manufacturer’s protocol, and the fluorescence was analyzed 
by ImageJ software. Twenty-four images were selected randomly and analyzed in each 
group. Four independent experiments were carried out. 
2.10. Measurement of Serum CK-MM Isoenzyme Levels.  
Blood was collected from the tail vein of mice at 23 and 65 weeks of age. The samples 
were incubated at room temperature for 20 min to allow clotting, and then centrifuged 
at 1,000 g for 20 min. The serum was collected and stored at -80°C until use. The 
serum level of the muscular isoform of creatine kinase (CK-MM) was measured in 
duplicate, using the CK-MM ELISA Kit (MBS705327, MyBioSource, San Diego, CA) 
according to the manufacturer’s instructions. 
2.11. Four-Limb Hanging Test.  
The four-limb hanging test was performed using mice at 37, 38, and 39 weeks of age. 
Mice were placed on a net, and then the net was inverted by hand. The hanging time 
was measured in 5 consecutive trials separated by 1-min intervals. Three independent 
experiments were performed, and the results are shown as the mean of 3 trials per 
group.  
2.12. Rotarod Test.  
To assess motor coordination, mdx mice were tested on the rotarod (Ugo Basile, Mount 
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Laurel, NJ) at 40 weeks of age. For training, mice were placed on the rotarod at 10 
rpm for 5 min, on 3 consecutive days before the beginning of the experiment. The 
rotarod was accelerated from 10 to 50 rpm in 2 min, and the time at which the mouse 
fell off was recorded. Each mouse underwent 5 consecutive trials separated by 5-min 
intervals, and the results are shown as the mean values of 5 trials per group.  
2.13. Data analysis.  
Data are presented as means ± SEM. Statistical significance was determined using an 
unpaired Student’s two-tailed t-test for 2 data sets. Differences between multiple 
groups were assessed by one-way analysis of variance (ANOVA) followed by the 
Tukey post hoc test. For all tests, P<0.05 was considered statistically significant. All 







3.1. Impaired Autophagy/Mitophagy and Increased ROS Levels in the Muscle of 
mdx Mice.  
Impaired autophagic flux has been reported in the muscle of mdx mice [28]. We 
examined the mRNA levels of mitophagy- and autophagy-related genes in the 
quadriceps of 22-week-old mdx mice and compared them with those in age-matched 
wild-type (WT) mice (Figure 1(a)). The mRNA expression levels of mitophagy-related 
genes, including Pink1, parkin, Bnip3, and Fundc1, were significantly reduced in the 
muscle of mdx mice. The expression levels of Becn1, Atg5, Map1lc3b, and p62, which 
are necessary for autophagy as well as mitophagy, were also lower in mdx than in WT 
mice (Figure 1(a)). The expression level of transcription factor EB (Tfeb), a positive 
regulator of autophagy-related genes [18], in mdx mice was downregulated to less than 
half the level in control mice (Figure 1(a)).  
To analyze the autophagic flux in the muscle of mdx mice, the protein levels of LC3-I, 
LC3-II, and p62 were monitored. LC3-I is processed to LC3-II during autophagosome 
formation, and then LC3-II is degraded after the autophagosome fuses with a lysosome. 
A low ratio of LC3-II to LC3-I levels (LC3-II/LC3-I) indicates an insufficiency in 
autophagosome formation, whereas a high LC3-II/LC3-I indicates insufficient 
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autophagosome degradation or enhanced autophagosome formation. p62 is 
necessary for autophagy, and inhibiting autophagy increases the p62 protein level. As 
shown in Figure 1(b), the LC3-II/LC3-I was significantly higher in mdx than in WT mice. 
Although the mRNA levels of p62 were decreased in mdx mice (Figure 1(a)), the p62 
protein levels were higher in mdx than in WT mice (Figure 1(c)). These results indicated 
that autophagy/mitophagy was suppressed in the muscle of mdx mice.  
mTORC1, a major negative regulator of autophagy, is activated in mdx mice [28]. Since 
mTORC1 phosphorylates eukaryotic initiation factor 4E-binding protein 1 (4EBP1), we 
examined the phosphorylation levels of 4EBP1 (P-4EBP1). We found that the P-
4EBP1 levels were significantly increased, suggesting that mTORC1 is activated, in 
the muscle of mdx mice (Figure 1(b)).  
Suppressing mitophagy increases ROS levels [19]. To monitor ROS levels, sections of 
skeletal muscle were stained with dihydroethidium (DHE). Cellular superoxide converts 
DHE to ethidium bromide, which stains nuclear DNA with red fluorescence. The DHE 
fluorescence levels were much higher (4.8-fold) in mdx than in WT mice (Figure 1(d)). 
Together, these findings indicated that defects in autophagy/mitophagy could be 




3.2. Restoration of Autophagy/Mitophagy by Resveratrol in the Muscle of mdx 
Mice.  
mdx mice were treated with 0.04, 0.4, or 4 g resveratrol/kg food, and the effect of 
resveratrol on autophagy/mitophagy was examined. The administration of resveratrol 
to mdx mice was started at 9 weeks of age, and the muscle tissues were examined at 
65 weeks of age. During the experiment, two untreated mdx mice, and 1, 1, and 2 mice 
receiving resveratrol at 0.04, 0.4, and 4 g/kg food, respectively, died of muscle tumors 
or unknown causes. No difference in the mean body weight was found among the 
untreated and resveratrol-treated mice at 34, 41, or 65 weeks of age (Table 1). The 
expression levels of mitophagy- and autophagy-related genes were significantly 
increased in the quadriceps of resveratrol-treated mdx mice compared with those of 
control mdx mice (Figure 2(a)). Approximately 2-fold increases in the Pink1, parkin, 
and p62 mRNA levels were found in mice treated with all three doses of resveratrol in 
food. The Bnip3, Fundc1, Atg5, Becn1, Map1lc3b, Tfeb, and Lamp1 levels were 
significantly upregulated by resveratrol at 0.04 and 4 g/kg food. The Bcl2l13 level was 
slightly but significantly elevated in the muscle of mdx mice treated with 4 g/kg food. 
Thus, resveratrol significantly increased the expression levels of mitophagy- and 
autophagy-related genes. In addition, resveratrol administered at 0.4 g/kg food 
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significantly increased the SIRT1 mRNA levels by 2- to 3-fold in the quadriceps, 
diaphragm, and tibialis anterior (Supplemental Figure 1(a)).  
An impairment in autophagic flux increases the ubiquitinated protein levels in tissues 
[19]. Western blot analysis showed that the administration of resveratrol dose-
dependently decreased the levels of ubiquitinated proteins (Figure 2(b)), suggesting 
that resveratrol promoted the removal of ubiquitinated proteins from the muscle by 
inducing autophagic flux. Actually, we observed that resveratrol administration 
increased the LC3-II/LC3-I at 0.4 and 4 g/kg food (Figure 2(c)), but it did not 
significantly increase the p62 protein level (Figure 2(d)). These observations indicated 
that resveratrol increased the autophagic flux in mdx mice. The phosphorylation levels 
of 4EBP1 were not reduced by resveratrol (Supplemental Figure 1(b)), indicating that 
resveratrol did not inhibit the mTORC1 activity. DHE staining of muscular sections 
showed that resveratrol significantly decreased the ROS levels in the muscle of mdx 
mice. The ROS levels in the quadriceps of mdx mice treated with 0.04, 0.4, and 4 g/kg 
were 29, 26, and 11% of those in untreated mdx mice, respectively (Figure 2(e)).  
3.3. Improvements in Skeletal Muscle Damage and Function in mdx Mice by 
Resveratrol.  
The autophagy/mitophagy restoration and ROS reduction by resveratrol may affect 
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muscle degeneration and regeneration. Since regenerating myofibers contain central 
nuclei, sections of the quadriceps from mdx mice at 65 weeks of age were treated with 
Hoechst 33342 and FITC-conjugated WGA to stain nuclei and plasma membranes, 
respectively, and examined by confocal microscopy (Figures 3(a) and 3(b)). 
Resveratrol treatment at all three doses significantly decreased the number of 
myofibers with central nuclei, showing that resveratrol reduced the number of newly 
generated myofibers. Analysis of the cross-sectional areas of myofibers revealed that 
resveratrol dose-dependently decreased the number of fine fibers (under 400 μm2 in 
cross-section area) compared with the number in untreated mdx mice (Figure 3(c)). In 
contrast, the number of wider myofibers (1,000 to 1,199 μm2 in cross-section area) 
was significantly increased by resveratrol administered at 4 g/kg food (Figure 3(c)). 
These results suggested that resveratrol decelerated the turnover rates and promoted 
the maturation of myofibers in mdx mice.  
Whether resveratrol affected number of satellite cells, mRNA levels of Pax 7, a marker 
of satellite cells, were measured in quadriceps and soleus of mdx mice. However, Pax7 
mRNA levels were not affected by resveratrol administration (Supplemental Figure 2). 
Recently, AMPK activation in satellite cells has been shown to inhibit apoptosis and 
promote muscle repair [29]. To detect AMPK activation, phosphorylation levels of 
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AMPK in quadriceps were examined, but we could not detect significant increase of 
activated AMPK levels by resveratrol (Supplemental Figure 3). 
The serum levels of CK-MM reflect skeletal muscle cell damage. Thus, to examine 
whether muscle injuries were attenuated by resveratrol, the serum CK-MM levels were 
examined. Resveratrol administered at 0.4 g/kg food to mdx mice significantly 
decreased the CK-MM levels to about one-third of those in untreated mdx mice at 23 
and 65 weeks of age (Figures 3(d) and 3(e)). At 65 weeks of age, the administration of 
resveratrol at 4 g/kg food also significantly decreased the CK-MM levels, which were 
less than half those observed in untreated mdx mice (Figure 3(e)).  
To investigate whether resveratrol improves skeletal muscle motor function, mdx mice 
were examined by the inverted hang test and the rotarod test, which reflect fatigue 
resistance and muscular coordination. At 37 weeks of age, the average hanging time 
in untreated mdx mice was 69 sec, and resveratrol treatment at 0.4 and 4 g/kg food 
significantly extended the time to 121 sec and 114 sec, respectively. At 40 weeks of 
age, an approximate 2-fold extension of riding time on the rotating rod was observed 
in mdx mice treated with resveratrol as low as 0.04 g/kg food (Figure 3(g)). Resveratrol 
at 0.4 g/kg and 4 g/kg food extended the riding time on the rotarod to durations similar 
to those seen with 0.04 g/kg food (Figure 3(g)). Therefore, treatment with resveratrol, 
21 
 
especially at a dose of 0.4 g/kg food, decreased the muscle injury and improved 
physical activities of mdx mice. 
3.4. Mitophagy Induction by Resveratrol in C2C12 Cells.  
Resveratrol induces autophagy [15, 16]. To examine whether resveratrol also promotes 
mitophagy, we examined the effect of resveratrol on mitophagy using C2C12 myoblast 
cells. Autophagosome formation can be monitored by the appearance of EGFP-LC3 
dots in cells [30]. EGFP-LC3 was expressed in C2C12 cells, and the number of EGFP-
LC3 dots was counted. Treating the cells with resveratrol significantly increased the 
number of EGFP-LC3 dots compared with control cells (Figures 4(a) and 4(b)). 
Treating the cells with chloroquine (CQ), which suppresses lysosome function thereby 
inhibiting the degradation of autophagosomes, increased the number of LC3 dots 
(Figures 4(a) and 4(b)). In the presence of CQ, resveratrol treatment further increased 
the number of LC3 dots (Figures 4(a) and 4(b)). These observations indicated that 
resveratrol enhanced autophagosome formation.  
To examine whether mitophagy was accelerated by resveratrol, we stained 
mitochondria with MitoTracker Red (MTR) and examined the colocalization of 
mitochondria with EGFP-LC3 dots. While there were few mitochondria-containing 
autophagosomes in the control cells, the administration of CQ significantly increased 
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the number of EGFP-LC3 dots colocalized with mitochondria (Figure 4(a)). Thus, in 
the absence of CQ, mitochondria were constantly degraded by mitophagy in C2C12 
cells (Figures 4(a) and 4(c)). Resveratrol significantly increased the number of EGFP-
LC3 dots colocalized with mitochondria in the absence of CQ (Figures 4(a) and 4(c)). 
The highest numbers of EGFP-LC3 dots colocalized with mitochondria were detected 
in cells treated with resveratrol and CQ (Figures 4(a) and 4(c)). These results indicated 
that resveratrol promoted both autophagy and mitophagy.   
3.5. Mitochondrial ROS Reduction by Resveratrol-induced Mitophagy.  
Antimycin A (AA), an inhibitor of the electron transport chain in mitochondria, 
depolarizes mitochondria and increases the mitochondrial ROS levels. C2C12 cells 
were treated with AA, and the mitochondrial ROS levels were monitored with MitoSOX 
Red, a fluorescent indicator of mitochondrial superoxide levels. Treating the cells with 
AA increased the mitochondrial ROS levels, and this increase was significantly 
suppressed by resveratrol (Figure 5(a)). The addition of CQ completely cancelled this 
effect of resveratrol on the ROS levels (Figure 5(a)), indicating that the autophagic flux 
was required for resveratrol’s anti-oxidative effect.  
Atg5, an E3 ubiquitin-like ligase, is involved in autophagic vesicle formation. Because 
Atg5 is deacetylated by SIRT1 [14], we examined the effect of Atg5 knockdown on 
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resveratrol’s function. Treating the C2C12 cells with Atg5-siRNA decreased the LC3-
II/LC3-I ratio, indicating that the Atg5-siRNA inhibited autophagy (Figures 5(b) and 
5(c)). MitoSOX Red staining showed that resveratrol failed to decrease the AA-induced 
ROS levels in cells treated with Atg5-siRNA (Figure 5(d)). Thus, disrupting 
autophagy/mitophagy with Atg5-siRNA inhibited resveratrol’s anti-oxidative function.  
Pink1 is indispensable for mitophagy [31]. Therefore, to inhibit mitophagy, C2C12 cells 
were treated with Pink1-siRNA (Figures 5(e), 5(f) and 5(g)). In the absence of AA, the 
knockdown of Pink1 alone altered the mitochondrial morphology and increased the 
size and area of mitochondria in C2C12 cells (Figures 5(e) and 5(f)), indicating that 
mitophagy was disrupted by the Pink1-siRNA. MitoSox Red staining showed that 
Pink1-siRNA completely cancelled resveratrol’s anti-oxidative function against AA 
(Figure 5(g)). These findings together indicated that the induction of mitophagy by 







Membrane fragility due to dystrophin deficiency causes intracellular Ca2+ dysregulation, 
resulting in mitochondrial dysfunction and ROS production [32]. Damaged 
mitochondria are a major source of cellular ROS and are selectively degraded by 
mitophagy, which decreases cellular ROS levels [17, 18, 19]. We showed that 
resveratrol induced mitophagy (Figure 4) and reduced the ROS levels in C2C12 cells 
in a mitophagy-dependent manner (Figure 5). Pink1-siRNA alone significantly 
increased the ROS levels in the absence of AA, indicating that mitophagy continuously 
contributes to the decrease in cellular ROS levels (Figure 5(g)). Although the 
knockdown efficiency by Atg5-siRNA was greater than that by Pink1-siRNA (Figures 
5(b) and 5(e)), Atg5-siRNA alone could not increase the ROS levels in the absence of 
AA (Figure 5(d)). Atg5 is dispensable for the mitophagy occurring during erythroid 
maturation and Atg5-independent mitophagy is found in various organs [33]. Thus, an 
Atg5-independent mitophagy pathway may contribute to decrease the ROS levels in 
C2C12 cells.  
The expression of autophagy-related genes, i.e., Atg12, Map1lc3b, Gabarapl1, and 
Bnip3, was previously shown to be suppressed in mdx mice [28]. In this study, we 
found that other autophagy/mitophagy-related genes, i.e., Pink1, parkin, Fundc1, 
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Becn1, Atg5, p62, and Tfeb, were downregulated in the quadriceps of mdx mice 
(Figure 1). TFEB is a master transcription factor for autophagy and lysosomal 
biogenesis [18]. Because the Tfeb mRNA levels were downregulated in mdx mice 
(Figure 1(a)), a decrease in TFEB level may downregulate autophagy/mitophagy-
related genes in mdx mice. In addition, increase in the P-4EBP1 levels suggested the 
activation of mTORC1 in mdx mice (Figure 1(b)). mTORC1 is reported to downregulate 
autophagy-related genes in animal models of muscular dystrophies and DMD patients 
[28, 34]. Consistent with this finding, inhibiting mTORC1 by administering a low-protein 
diet or rapamycin ameliorates dystrophic muscle phenotypes [28, 34]. Since TFEB is 
phosphorylated and excluded from the nucleus by mTORC1, TFEB’s inactivation by 
mTORC1 may also contribute to the downregulation of autophagy/mitophagy-related 
genes. We found that resveratrol restored the expression levels of 
autophagy/mitophagy machineries and autophagic flux (Figures 2(a), 2(b) and 2(c)). 
However, the phosphorylation levels of 4EBP1 were not changed by resveratrol 
(Supplemental Figure 1(b)), indicating that resveratrol did not affect the mTORC1 
activity. FOXOs are known to positively regulate autophagy/mitophagy-related genes 
[19]. We previously showed that resveratrol decreases ROS levels in C2C12 cells by 
promoting the activation of FOXOs [35]. Because the knockdown of Foxos, i.e., Foxo1, 
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Foxo3a, and Foxo4, by their siRNAs completely inhibited resveratrol’s anti-oxidative 
function in AA-treated C2C12 cells [35], the activation of FOXOs by resveratrol may 
upregulate the autophagy/mitophagy-related genes and facilitate the 
autophagy/mitophagy flux in mdx mice. In addition, the upregulation of Sirt1 mRNA by 
resveratrol in mdx mice (Supplemental Figure 1(a)) may have been caused by the 
activation of FOXOs, since FOXOs also induce Sirt1 mRNA [4]. 
SIRT1-siRNA also inhibits resveratrol’s anti-oxidative function in AA-treated C2C12 
cells [35], suggesting that resveratrol activates FOXOs via SIRT1 activation in mdx 
mice. In addition, the deacetylation and activation of Atg5, Atg7, and LC3 by SIRT1 
could be involved in the increased autophagy/mitophagy flux caused by resveratrol.  
Recently, mitochondrial dysfunction and mitophagy insufficiency were shown to be 
involved in the pathogenesis of progeroid syndromes. Mitophagy disturbance worsens 
the phenotypes of Xeroderma pigmentosum group A-deficiency (XPA) and ataxia 
telangiectasia (AT), both of which are DNA repair disorders [36, 37]. DNA-repair failure 
activates poly (ADP-ribose) polymerase 1 (PARP1), and then NAD+ is depleted by the 
activated PARP1, thereby decreasing the activity of the NAD+-dependent deacetylase 
SIRT1. Increased NAD+ levels activate SIRT1’s activity, and indeed, activating SIRT1 
by adding nicotinamide riboside, an NAD+ precursor, improves the mitochondria quality 
27 
 
via mitophagy induction and retards the progression of the DNA repair disorders [36, 
37]. Importantly, mdx mice have been shown to have increased PARP activities and 
low NAD+ levels in their muscle tissues [38]. Because PARP is activated by DNA 
damage, mdx mice are expected to have enhanced levels of DNA damage, which may 
be derived from the disturbance of mitophagy. Replenishing the NAD+ by administering 
nicotinamide riboside reduced the nuclear ADP-ribosylated protein levels and 
improved the muscle function and heart pathology in mdx mice [38]. Similar to XPA 
and AT, nicotinamide riboside may induce mitophagy and ameliorate phenotypes of 
dystrophin-deficient mice. Since nicotinamide riboside is much more costly than 
resveratrol, resveratrol has an economic advantage over nicotinamide riboside to treat 
DMD.  
Stem cell depletion also plays a role in the progression of muscular dystrophies [3, 39]. 
SIRT1 induces the proliferation of myoblast cells, and muscle-specific SIRT1-knockout 
mice exhibit impaired muscle regeneration [40]. Because resveratrol appeared to 
decelerate the muscular turnover rate and to suppress excess muscle regeneration 
(Figures 3(a), 3(b) and 3(c)), resveratrol may preserve the number of muscle stem cells 
in DMD. However, resveratrol administration to mdx mice did not increase Pax7 
expression levels (Supplemental Figure 2). Thus, the resveratrol’s main function on 
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the muscle of mdx mice seems to inhibit cell death by reducing oxidative stress and 
promote maturation of muscle cells.  
In this study, we administered resveratrol to mdx mice at three doses to determine its 
optimal dose. The most effective dose of resveratrol was 0.4 g/kg food for muscle injury, 
function, and autophagic activity, although the administration of resveratrol at 0.04 g/kg 
or 4 g/kg was also effective. Because resveratrol is rather hydrophobic, it may 
accumulate in lipids such as cellular membranes and adipose tissues. For its clinical 
evaluation, the optimal dosage of resveratrol for treating muscular dystrophies needs 
to be determined. Our findings indicate that resveratrol would be effective for muscular 
dystrophy patients and may provide a combination therapy with other medicines such 
as glucocorticoids.  
 
Abbreviations: 
AA:  Antimycin A 
CK-MM: Muscular isoform of creatine kinase 
CQ:  Chloroquine 
DHE:   Dihydroethidium 
DMD:  Duchenne muscular dystrophy 
4EBP1:  Eukaryotic initiation factor 4E-binding protein 1 
FOXOs: Forkhead box O transcription factors 
Mitophagy: Autophagy of damaged mitochondria 
mTORC1: Mechanistic target of rapamycin complex 1 
MTR:  MitoTracker Red 
PGC-1α: Peroxisome proliferator-activated receptor  
              gamma coactivator 1-alpha  
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Pink1:  PTEN-induced putative kinase 1 
ROS:  Reactive oxygen species 
RSV:  Resveratrol 
SOD2:  Superoxide dismutase 2 
WGA:  Wheat germ agglutinin 
WT:  Wild type 
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Supplemental Figure 1. 
Effects of resveratrol on SIRT1 expression and P-4EBP1 levels of muscles from 
mdx mice. 
(a) SIRT1 mRNA levels analysed by a qPCR method in quadriceps, diaphragm, and 
tibialis anterior (TA) muscles from untreated and resveratrol (RSV)-treated mdx mice. 
n=4. (b) Representative Western blots (upper) and summary data (lower) for P-4EBP1 
and total 4EBP1 in muscles from mdx mice. n=4. *P<0.05, NS: not significant. 
 
Supplemental Figure 2. 
Effects of resveratrol on Pax7 mRNA expression levels of muscles from mdx 
mice. 
Pax7 mRNA levels analysed by a qPCR method in quadriceps and soleus muscles 
from untreated and resveratrol (RSV)-treated mdx mice. n=4. NS: not significant. 
 
Supplemental Figure 3. 




Representative Western blots (upper) and summary data (lower) for P-AMPK 
andAMPK in muscles from mdx mice. n=4. NS: not significant. 
 
Supplemental Table 1.  Primer sequences for quantitative PCR. 
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Legends for Figures 
Figure 1. Downregulation of mitophagy and autophagy and increased ROS 
levels in the muscle of mdx mice.  (a) Expression levels of mitophagy- and 
autophagy-related genes in the quadriceps muscle of WT and mdx mice at 22 weeks 
of age. Data were normalized to 18s ribosomal RNA. n=4. (b) (Upper) Representative 
Western blots for LC3, phosho-Ser65-4EBP1 (P-4EBP1), and total 4EBP1 in the 
quadriceps muscle. (Lower) Summary data of the LC3-II/LC3-I ratio and P-4EBP1 
levels normalized to the total 4EBP1 level in the muscle. n=4. (c) Representative 
Western blots for p62 in the quadriceps muscle (upper) and summary data (lower). 
n=4. (d) Representative dihydroethidium (DHE) staining in the quadriceps (left) and 
summary data of DHE fluorescence (right). Six randomly selected images were 
captured in each muscle section, and 4 mice were analyzed in each group. Scale 
bar: 50 μm. *P<0.05. WT: wild type.  
 
Figure 2. Effects of resveratrol on mitophagy, autophagy, and ROS levels in the 
muscle of mdx mice.  (a) Expression levels of mitophagy- and autophagy-related 
genes in the quadriceps muscle from untreated mdx mice and mdx mice treated with 
resveratrol (RSV) at 0.04, 0.4, and 4 g/kg food (RSV-0.04, RSV-0.4, and RSV-4, 
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respectively). n = 4 in each group. (b) Western blot analysis for ubiquitinated proteins 
in the quadriceps. (c) Representative Western blots for LC3 in the muscle tissue (left) 
and summary data of the LC3-II/LC3-I ratio (right). n=4 in each group. (d) 
Representative Western blot for p62 in muscle (left) and summary data of p62 
normalized to the GAPDH level (right). n=4 in each group. (e) Representative 
dihydroethidium (DHE) staining in the quadriceps (upper) and summary data of DHE 
fluorescence intensity (lower). Six randomly selected images were captured in each 
muscle section, and 4 mice were analyzed in each group. Scale bar: 50 μm. *P<0.05. 
**P<0.01. NS: not significant. 
 
Figure 3. Resveratrol decreases muscular injury and improves muscle function 
in mdx mice. (a) Representative images of quadriceps stained with FITC-conjugated 
wheat germ agglutinin (WGA, green) and Hoechst 33342 (blue) to detect myofiber 
membranes and nuclei, respectively. Muscle sections were obtained from untreated 
and resveratrol-treated mdx mice. Scale bar: 50 μm. (b) Percentage of myofibers with 
central nuclei in mdx mice. n=4 in each group. (c) Cross-sectional area of myofibers 
in the quadriceps muscles in mdx mice. n=4 mice per group. (d, e) Serum levels of 
the muscle isoform of creatine kinase (CK-MM) in the mdx mice at 23 (d) and 65 
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weeks old (e). n=5-6 mice per group. (f) Hanging time assessed by the inverted hang 
test of mdx mice at 37 weeks of age. (g) Rotarod riding time in mdx mice at 40 weeks 
of age. n=4-5 mice per group. *P<0.05; **P<0.01. 
 
Figure 4. Resveratrol Induces mitophagy in C2C12 cells.  (a) Representative 
images of EGFP-LC3 and MitoTracker Red (MTR), and the merged images in C2C12 
cells. Cells were cultured in the absence or presence of resveratrol (RSV, 30 μM), 
chloroquine (CQ, 50 μM), or RSV and CQ together, for 6 h. Yellow indicates EGFP-
LC3 dots (green) colocalized with mitochondria (red). Scale bar: 10 μm. (b) Summary 
data of the number of LC3 dots per cell. (c) Summary data of the number of EGFP-
LC3 dots colocalized with fragmented mitochondria per cell. In (c) and (d), the data 
were obtained from 40 randomly selected cells from 4 independent experiments. 
*P<0.05; **P<0.01. 
 
Figure 5. Resveratrol decreases ROS levels via mitophagy in C2C12 cells.  
(a) (Left) Representative images of MitoSOX Red fluorescence in C2C12 cells. Cells 
were cultured with vehicle (Veh), antimycin A (AA, 10 μM), or AA and resveratrol 
(RSV, 30 μM) in the presence or absence of chloroquine (CQ, 50 μM) for 24 h. 
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(Right) Summary data of MitoSOX Red fluorescence intensity per cell. n=6. Scale 
bar: 50 μm. (b) mRNA level of Atg5 normalized to 18s ribosomal RNA in C2C12 cells 
transfected with control (Ctrl) siRNA or siRNA against mouse Atg5. n=4. (c) 
Representative Western blot for LC3 in cells transfected with control or Atg5 siRNA in 
C2C12 cells. n=4. (d) (Left) Representative images of MitoSOX Red fluorescence in 
C2C12 cells transfected with control or Atg5 siRNA and treated with vehicle, AA, or 
AA and resveratrol for 24 h. Scale bar: 50 μm. (Right) Summary data of MitoSOX 
Red fluorescence intensity. n=6. (e) Level of Pink1 mRNA in cells treated with control 
or Pink1 siRNA in C2C12 cells. n=4. (f) (Left) Representative images of MitoTracker 
Red (MTR) fluorescence in C2C12 cells transfected with control or Pink1 siRNA. 
Scale bar: 10 μm. (Right) Summary data of MitoTracker Red fluorescence intensity. 
n=4. (g) (Left) Representative images of MitoSOX Red fluorescence in C2C12 cells 
transfected with control or Pink1 siRNA and treated with vehicle, AA, or AA and 
resveratrol for 24 h. Scale bar: 50 μm. (Right) Summary data of MitoSOX Red 





Table 1. Effect of resveratrol on body weight in mdx mice. 
Age (weeks) 
Dose of resveratrol (g/kg food) 
0 0.04 0.4 4 
Body weight (g) 
34 34±1 33±0 32±1 34±1 
41 35±1 34±0 33±2 34±1 
65 33±2 31±0 30±1 31±1 
No significant difference was observed in the body weight of mdx mice treated with 0, 
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